After a decade of global research involving 22,000 experts, PCOS has been officially renamed PMOS – Polyendocrine Metabolic Ovarian Syndrome – in a landmark paper published in The Lancet on May 12, 2026. Here is everything you need to know about what this means for symptoms, fertility, and specialist care in the UAE.
PMOS (Polyendocrine Metabolic Ovarian Syndrome) is the official new name for PCOS, confirmed in a landmark global consensus published in The Lancet on May 12, 2026 – the result of an 11-year process involving 22,000 clinicians, researchers, and patients worldwide. The name change is now endorsed by 56 major academic and patient organisations globally. PMOS affects 1 in 8 women (170 million worldwide). In Dubai, specialist fertility clinics offer comprehensive PMOS diagnosis, hormonal management, and advanced fertility treatments, including IUI and IVF.
What was previously discussed as an emerging terminology shift is now confirmed science. On May 12, 2026, the international medical community formally retired the name PCOS and replaced it with PMOS – Polyendocrine Metabolic Ovarian Syndrome – through a rigorous, decade-long global consensus process led by Professor Helena Teede at Monash University, Australia.
Published in The Lancet – May 12, 2026
“Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process” – simultaneously presented at the European Congress of Endocrinology in Prague.
Reference: Teede HJ, Bahri Khomami M, Morman R, et al. The Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00717-8
Over 11 years, approximately 22,000 stakeholders – including doctors, researchers, patients, and patient advocacy groups from around the world – contributed to shaping the new name. PMOS was the near-unanimous winner, chosen over two other finalists: Endocrine Metabolic Ovulatory Syndrome and Ovulatory Metabolic Endocrine Syndrome.
The new name is now endorsed by over 56 leading academic, clinical, and patient organisations globally, and a rollout plan spanning 195 countries over 3 years has been put into motion – covering updates to clinical guidelines, medical education curricula, and international disease classification systems (including ICD codes).
For women in Dubai and the UAE currently living with a PCOS diagnosis, this change has immediate practical meaning: your existing diagnosis remains fully valid, and your care pathway does not change overnight. What the renaming does is signal that clinicians will increasingly approach the condition through a broader hormonal and metabolic lens – which is better for your long-term health outcomes.
PMOS – Polyendocrine Metabolic Ovarian Syndrome – is the contemporary, more accurate term for the condition most people know as PCOS (Polycystic Ovary Syndrome). The terminology shift is being driven by leading reproductive medicine researchers and endocrinologists who argued the original name was misleading and incomplete.
Breaking the acronym down: “polyendocrine” refers to the involvement of multiple hormone-secreting glands, and “metabolic” emphasises the condition’s deep connection to insulin function, blood sugar regulation, and body weight. The result is a name that more honestly describes what patients and clinicians are actually dealing with.
The push to replace PCOS with PMOS had been growing within the reproductive medicine community for years – and in May 2026, it became official. The core problem the rename addresses: the original name was built around a specific anatomical finding – polycystic ovaries – that is neither present in every patient nor the defining feature of the disorder.
PCOS focused on:
PMOS reflects:
Research confirms that only around 75% of women diagnosed under PCOS criteria actually show polycystic-appearing ovaries on ultrasound. The remaining patients may carry the diagnosis for years without their full hormonal picture being addressed. The PMOS nomenclature is designed to close that gap.
Because PMOS affects the interplay between the endocrine system and metabolic function, its symptoms span multiple body systems. This is precisely why many women spend years searching for answers – the condition may be mistaken for thyroid disorders, depression, or simple weight issues.
Note: If you experience three or more of the above signs – especially in combination with irregular periods – speak to a fertility or endocrine specialist in Dubai.
One of the strongest reasons for the terminology shift to PMOS is insulin resistance – a metabolic dysfunction affecting up to 70% of women with the condition. Insulin resistance occurs when cells in the body fail to respond normally to insulin, causing the pancreas to produce more to compensate.
In the context of PMOS, excess insulin directly stimulates the ovaries to produce additional androgens (male hormones), which disrupts the follicular development needed for regular ovulation. The downstream effects include:
Recognising insulin resistance as a central driver – not a side effect – is why PMOS treatment now increasingly includes metabolic interventions alongside traditional hormonal therapies.
Fertility challenges are among the most distressing aspects of PMOS for many women in Dubai and across the UAE. The condition can affect conception at several stages of the reproductive cycle.
The most common fertility-related effects of PMOS include:
However, a PMOS diagnosis is not a verdict against motherhood. With the correct clinical approach, a significant proportion of women with PMOS successfully conceive – both naturally after lifestyle intervention and with structured fertility treatment. Success rates improve considerably with early diagnosis and a personalised care plan.
Accurate diagnosis of PMOS requires a thorough clinical evaluation. Because its symptoms overlap with thyroid disorders, hyperprolactinaemia, and adrenal conditions, specialist assessment is essential. In Dubai, leading fertility clinics follow evidence-based diagnostic protocols:
Effective PMOS treatment in Dubai combines hormonal, metabolic, and reproductive interventions tailored to each patient’s specific profile, age, and fertility goals. There is no single protocol – personalisation is key.
Structured weight management, low-glycaemic dietary plans, and exercise programmes. Even 5-10% weight loss can restore ovulation in many women.
Metformin and newer agents help the body respond to insulin more effectively, reducing androgen levels and improving cycle regularity.
Tailored hormonal therapies to regulate menstrual cycles, reduce excess androgens, and address acne and hirsutism.
Oral and injectable medications to stimulate regular follicle development and egg release, closely monitored by ultrasound.
Intrauterine insemination combined with ovulation induction for couples with PMOS-related fertility challenges.
Advanced IVF with tailored stimulation protocols designed to reduce the risk of ovarian hyperstimulation in PMOS patients.
The hormonal fluctuations, physical symptoms, and fertility challenges of PMOS carry a significant emotional weight. Studies indicate that women with PMOS experience higher rates of anxiety, depression, and body image concerns compared to the general population.
Comprehensive PMOS care in Dubai recognises psychological wellbeing as integral to treatment. Evidence-based approaches include:
Women going through PMOS treatment should know that emotional responses to this diagnosis are valid, and that seeking psychological support is a recognised and recommended part of the clinical pathway.
One of the strongest arguments for adopting the PMOS framework is its power to improve long-term health outcomes. When the condition is understood only as an ovarian issue, important systemic risks are easily overlooked. Left unmanaged, PMOS carries elevated risks including:
Early diagnosis, lifestyle modification, and appropriate medical management significantly reduce these long-term risks – making specialist evaluation in your reproductive years one of the most important investments in long-term health.
PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. It is the official new name – confirmed in The Lancet, May 2026 – for what was previously called PCOS. The new name better captures the condition’s impact on multiple hormone-producing glands and on metabolic health. Clinically, the condition and its management remain the same; the terminology evolved to improve understanding and diagnosis.
The original name was clinically misleading – not all women with the condition develop ovarian cysts, and the disorder’s primary drivers (multi-gland hormonal dysregulation and insulin resistance) were obscured by the name. Research showed the old terminology led to diagnostic delays in up to 70% of cases.
Yes. A PMOS diagnosis does not mean you cannot conceive. While the condition can disrupt ovulation, many women with PMOS successfully become pregnant – both naturally following lifestyle changes and with fertility treatments such as ovulation induction, IUI, or IVF. Early diagnosis and a personalised fertility plan significantly improve the chances of a successful pregnancy.
In Dubai, PMOS is diagnosed through detailed clinical history, hormone blood tests (LH, FSH, AMH, testosterone, thyroid function), glucose and insulin testing, pelvic ultrasound, and a comprehensive metabolic risk assessment. Specialist input from a fertility or endocrine doctor is important due to symptom overlap with other conditions.
Treatment typically includes lifestyle and nutritional therapy, insulin-sensitising medications (such as metformin), hormonal treatments to regulate cycles and manage androgen symptoms, and fertility-specific interventions such as ovulation induction, IUI, or IVF for women trying to conceive. The best approach depends on your individual symptoms, hormonal profile, and reproductive goals.
Yes. PMOS and PCOS are the same condition. PMOS is the official new name confirmed in The Lancet on May 12, 2026. If you have been diagnosed with PCOS, your diagnosis remains fully valid – the rename does not change your care pathway, but signals a more comprehensive approach to treatment going forward.
Evidence-based lifestyle changes include a low-glycaemic diet rich in whole foods, regular moderate exercise (150+ minutes per week), achieving and maintaining a healthy weight, prioritising quality sleep (7-9 hours), and managing chronic stress. Even a 5-10% reduction in body weight can significantly improve ovulation and hormone balance in many women.
PMOS – Polyendocrine Metabolic Ovarian Syndrome – is no longer just an emerging term. As of May 12, 2026, it is the official name for the condition affecting 1 in 8 women worldwide, confirmed by a global scientific consensus published in The Lancet. The rename marks a turning point in how this complex, multi-system hormonal condition is understood, diagnosed, and treated.
For women in Dubai and the UAE, this means access to more accurate diagnosis, more targeted treatment, and better long-term health outcomes. Whether you are managing symptoms, planning a pregnancy, or seeking specialist care, early intervention remains the most powerful tool available.
Orchid Fertility Clinic provides advanced PMOS assessment, hormone evaluation, IVF support, and personalised fertility treatment for women seeking expert reproductive care in Dubai and the UAE. Our experienced fertility specialists support women through every step of their hormonal wellness journey.
Search Doctors/ Treatment Options / Infertility Factors
